Zhengye Biotechnology Holding Ltd.

06/25/2026 | Press release | Distributed by Public on 06/25/2026 09:42

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Han Zhenfa
2. Date of Event Requiring Statement (Month/Day/Year)
06/25/2026
3. Issuer Name and Ticker or Trading Symbol
Zhengye Biotechnology Holding Ltd [ZYBT]
(Last) (First) (Middle)
NO.1 LIANMENG ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
JILIN CITY 132101
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Ordinary shares, par value US$0.000025 per share(1) 40,000,000 I By Securingium Holding Limited
Ordinary shares, par value US$0.000025 per share(1) 2,278,752 I By Vanguards Skyline Holdings Limited
Ordinary shares, par value US$0.000025 per share(1) 684,996 I By VVAX Holdings Limited
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Han Zhenfa
NO.1 LIANMENG ROAD
JILIN CITY 132101
X X

Signatures

/s/ Zhenfa Han 06/25/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents (i) 40,000,000 ordinary shares held by Securingium Holding Limited, a BVI business company, 99.99% owned by TSset Holding Limited, which is in turn 100% owned by Trident Trust Company (HK) Limited as trustee of Generations United Trust, of which Zhenfa Han is. the settlor, beneficiary, and protector; (ii) 2,278,752 ordinary shares held by Vanguards Skyline Holdings Limited, a BVI business company, 100% owned by Changchun Feier Investment Center (Limited Partnership), which is 19.79% owned and ultimately controlled as managing partner by Zhenfa Han; and (iii) 684,996 ordinary shares held by VVAX Holdings Limited, a BVI business company, which is 100% owned by Jilin Zhengye Group Co., Ltd., which is 99% owned by Zhenfa Han. The business address of Securingium Holding Limited, Vanguards Skyline Holdings Limited, and VVAX Holdings Limited is No. 1 Lianmeng Road, Jilin Economic & Technical Development Zone, Jilin City, Jilin Province, China.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Zhengye Biotechnology Holding Ltd. published this content on June 25, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 25, 2026 at 15:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]